-
Je něco špatně v tomto záznamu ?
Molecular Genetic Aspects of Sporadic Multiglandular Primary Hyperparathyroidism
J. Včelák, Z. Šerková, K. Zajíčková
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- lidé MeSH
- molekulární biologie MeSH
- parathormon genetika MeSH
- paratyreoidea patologie MeSH
- primární hyperparatyreóza * diagnóza genetika patologie MeSH
- retrospektivní studie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Multiglandular primary hyperparathyroidism (MGD) represents a rare form of primary hyperparathyroidism (PHPT). MGD is associated with hereditary PHPT, but the sporadic MGD is more common and affects a similar patient profile as single gland parathyroid disease (SGD). The distinction between SGD and MGD is of great clinical importance, especially for the strategy of parathyroidectomy. Based on the limited knowledge available, MGD is likely to be a genetically heterogeneous disease resulting from the interaction of germline and somatic DNA mutations together with epigenetic alterations. Furthermore, these events may combine and occur independently in parathyroid tumors within the same individual with MGD. Gene expression profiling has shown that SGD and MGD may represent distinct entities in parathyroid tumorigenesis. We are waiting for studies to analyze exactly which genes are different in SGD and MGD in order to identify potential biomarkers that can distinguish between the two forms of the disease.
1st Faculty of Medicine Charles University Czech Republic
2nd Faculty of Medicine Motol University Hospital Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022234
- 003
- CZ-PrNML
- 005
- 20250502125012.0
- 007
- ta
- 008
- 240104s2023 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.935253 $2 doi
- 035 __
- $a (PubMed)38116772
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Včelák, Josef, $d 1971- $7 xx0107261 $u Institute of Endocrinology, Prague, Czech Republic. kzajickova@endo.cz $u First Faculty of Medicine Charles University, Czech Republic
- 245 10
- $a Molecular Genetic Aspects of Sporadic Multiglandular Primary Hyperparathyroidism / $c J. Včelák, Z. Šerková, K. Zajíčková
- 520 9_
- $a Multiglandular primary hyperparathyroidism (MGD) represents a rare form of primary hyperparathyroidism (PHPT). MGD is associated with hereditary PHPT, but the sporadic MGD is more common and affects a similar patient profile as single gland parathyroid disease (SGD). The distinction between SGD and MGD is of great clinical importance, especially for the strategy of parathyroidectomy. Based on the limited knowledge available, MGD is likely to be a genetically heterogeneous disease resulting from the interaction of germline and somatic DNA mutations together with epigenetic alterations. Furthermore, these events may combine and occur independently in parathyroid tumors within the same individual with MGD. Gene expression profiling has shown that SGD and MGD may represent distinct entities in parathyroid tumorigenesis. We are waiting for studies to analyze exactly which genes are different in SGD and MGD in order to identify potential biomarkers that can distinguish between the two forms of the disease.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a primární hyperparatyreóza $x diagnóza $x genetika $x patologie $7 D049950
- 650 _2
- $a parathormon $x genetika $7 D010281
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a paratyreoidea $x patologie $7 D010280
- 650 _2
- $a molekulární biologie $7 D008967
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šerková, Zora $7 xx0329825 $u 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Zajíčková, Kateřina $7 xx0081901 $u Institute of Endocrinology, Prague, Czech Republic $u First Faculty of Medicine Charles University, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, Suppl. 4 (2023), s. S357-S363
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38116772 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20240104 $b ABA008
- 991 __
- $a 20250502125004 $b ABA008
- 999 __
- $a ok $b bmc $g 2283447 $s 1208678
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 72 $c S4 $d S357-S363 $e 2023Dec17 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
- LZP __
- $b NLK124 $a Pubmed-20240104